CD25 expression and outcomes in older patients with acute myelogenous leukemia treated with plerixafor and decitabine
Author:
Affiliation:
1. Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA;
2. Department of Healthcare Policy and Research, Division of Biostatistics and Epidemiology, Weill Cornell Medicine, New York, NY, USA
Funder
Leukemia and Lymphoma Society
Irma T Hirschl Trust
Clinical and Translational Science Center at Weill Cornell
National Cancer Institute
Publisher
Informa UK Limited
Subject
Cancer Research,Oncology,Hematology
Link
https://www.tandfonline.com/doi/pdf/10.1080/10428194.2017.1352089
Reference31 articles.
1. Role of Microenvironment in Resistance to Therapy in AML
2. Acute myelogenous leukemia stem cells: From Bench to Bedside
3. Identification of Therapeutic Targets for Quiescent, Chemotherapy-Resistant Human Leukemia Stem Cells
4. Interleukin-2 receptor alpha-chain (CD25) expression on leukaemic blasts is predictive for outcome and level of residual disease in AML
5. CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Chimeric antigen-receptor (CAR) engineered natural killer cells in a chronic myeloid leukemia (CML) blast crisis model;Frontiers in Immunology;2024-01-08
2. Prognostic significance of ASXL1 mutations in acute myeloid leukemia: A systematic review and meta-analysis;CASP J INTERN MED;2024
3. Prognostic value of ASXL1 mutations in patients with myelodysplastic syndromes and acute myeloid leukemia: A meta‐analysis;Asia-Pacific Journal of Clinical Oncology;2022-12-05
4. Markers and Reporters to Reveal the Hierarchy in Heterogeneous Cancer Stem Cells;Frontiers in Cell and Developmental Biology;2021-06-03
5. Interaction network of proteins associated with unfavorable prognosis in acute myeloid leukemia;Acta Biochimica Polonica;2020-12-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3